These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19527033)

  • 1. One scaffold, three binding modes: novel and selective pteridine reductase 1 inhibitors derived from fragment hits discovered by virtual screening.
    Mpamhanga CP; Spinks D; Tulloch LB; Shanks EJ; Robinson DA; Collie IT; Fairlamb AH; Wyatt PG; Frearson JA; Hunter WN; Gilbert IH; Brenk R
    J Med Chem; 2009 Jul; 52(14):4454-65. PubMed ID: 19527033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Novel Potential Inhibitors of Pteridine Reductase 1 in
    Kimuda MP; Laming D; Hoppe HC; Tastan Bishop Ö
    Molecules; 2019 Jan; 24(1):. PubMed ID: 30609681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections.
    Linciano P; Pozzi C; Iacono LD; di Pisa F; Landi G; Bonucci A; Gul S; Kuzikov M; Ellinger B; Witt G; Santarem N; Baptista C; Franco C; Moraes CB; Müller W; Wittig U; Luciani R; Sesenna A; Quotadamo A; Ferrari S; Pöhner I; Cordeiro-da-Silva A; Mangani S; Costantino L; Costi MP
    J Med Chem; 2019 Apr; 62(8):3989-4012. PubMed ID: 30908048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of novel inhibitors of Trypanosoma brucei pteridine reductase 1.
    Spinks D; Ong HB; Mpamhanga CP; Shanks EJ; Robinson DA; Collie IT; Read KD; Frearson JA; Wyatt PG; Brenk R; Fairlamb AH; Gilbert IH
    ChemMedChem; 2011 Feb; 6(2):302-8. PubMed ID: 21275054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution crystal structure of Trypanosoma brucei pteridine reductase 1 in complex with an innovative tricyclic-based inhibitor.
    Landi G; Linciano P; Tassone G; Costi MP; Mangani S; Pozzi C
    Acta Crystallogr D Struct Biol; 2020 Jun; 76(Pt 6):558-564. PubMed ID: 32496217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic Activity.
    Di Pisa F; Landi G; Dello Iacono L; Pozzi C; Borsari C; Ferrari S; Santucci M; Santarem N; Cordeiro-da-Silva A; Moraes CB; Alcantara LM; Fontana V; Freitas-Junior LH; Gul S; Kuzikov M; Behrens B; Pöhner I; Wade RC; Costi MP; Mangani S
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28282886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases.
    Tulloch LB; Martini VP; Iulek J; Huggan JK; Lee JH; Gibson CL; Smith TK; Suckling CJ; Hunter WN
    J Med Chem; 2010 Jan; 53(1):221-9. PubMed ID: 19916554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the
    Shamshad H; Hafiz A; Althagafi II; Saeed M; Mirza AZ
    Curr Comput Aided Drug Des; 2020; 16(5):583-598. PubMed ID: 31453790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development.
    Cavazzuti A; Paglietti G; Hunter WN; Gamarro F; Piras S; Loriga M; Allecca S; Corona P; McLuskey K; Tulloch L; Gibellini F; Ferrari S; Costi MP
    Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1448-53. PubMed ID: 18245389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Insights into the Development of Cycloguanil Derivatives as
    Landi G; Linciano P; Borsari C; Bertolacini CP; Moraes CB; Cordeiro-da-Silva A; Gul S; Witt G; Kuzikov M; Costi MP; Pozzi C; Mangani S
    ACS Infect Dis; 2019 Jul; 5(7):1105-1114. PubMed ID: 31012301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design and synthesis of antiparasitic pyrrolopyrimidines targeting pteridine reductase 1.
    Khalaf AI; Huggan JK; Suckling CJ; Gibson CL; Stewart K; Giordani F; Barrett MP; Wong PE; Barrack KL; Hunter WN
    J Med Chem; 2014 Aug; 57(15):6479-94. PubMed ID: 25007262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could chroman-4-one derivative be a better inhibitor of PTR1? - Reason for the identified disparity in its inhibitory potency in Trypanosoma brucei and Leishmania major.
    Omolabi KF; Iwuchukwu EA; Odeniran PO; Soliman MES
    Comput Biol Chem; 2021 Feb; 90():107412. PubMed ID: 33199197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a 2,4-diaminopyrimidine scaffold targeting Trypanosoma brucei pteridine reductase 1 from the LIBRA compound library screening campaign.
    Linciano P; Cullia G; Borsari C; Santucci M; Ferrari S; Witt G; Gul S; Kuzikov M; Ellinger B; Santarém N; Cordeiro da Silva A; Conti P; Bolognesi ML; Roberti M; Prati F; Bartoccini F; Retini M; Piersanti G; Cavalli A; Goldoni L; Bertozzi SM; Bertozzi F; Brambilla E; Rizzo V; Piomelli D; Pinto A; Bandiera T; Costi MP
    Eur J Med Chem; 2020 Mar; 189():112047. PubMed ID: 31982652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and reactivity of Trypanosoma brucei pteridine reductase: inhibition by the archetypal antifolate methotrexate.
    Dawson A; Gibellini F; Sienkiewicz N; Tulloch LB; Fyfe PK; McLuskey K; Fairlamb AH; Hunter WN
    Mol Microbiol; 2006 Sep; 61(6):1457-68. PubMed ID: 16968221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D-QSAR based pharmacophore modeling and virtual screening for identification of novel pteridine reductase inhibitors.
    Dube D; Periwal V; Kumar M; Sharma S; Singh TP; Kaur P
    J Mol Model; 2012 May; 18(5):1701-11. PubMed ID: 21826447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution structures of Trypanosoma brucei pteridine reductase ligand complexes inform on the placement of new molecular entities in the active site of a potential drug target.
    Dawson A; Tulloch LB; Barrack KL; Hunter WN
    Acta Crystallogr D Biol Crystallogr; 2010 Dec; 66(Pt 12):1334-40. PubMed ID: 21123874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1.
    Pöhner I; Quotadamo A; Panecka-Hofman J; Luciani R; Santucci M; Linciano P; Landi G; Di Pisa F; Dello Iacono L; Pozzi C; Mangani S; Gul S; Witt G; Ellinger B; Kuzikov M; Santarem N; Cordeiro-da-Silva A; Costi MP; Venturelli A; Wade RC
    J Med Chem; 2022 Jul; 65(13):9011-9033. PubMed ID: 35675511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase.
    Ferrari S; Morandi F; Motiejunas D; Nerini E; Henrich S; Luciani R; Venturelli A; Lazzari S; Calò S; Gupta S; Hannaert V; Michels PA; Wade RC; Costi MP
    J Med Chem; 2011 Jan; 54(1):211-21. PubMed ID: 21126022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of a simple quantum chemical approach to ligand fragment scoring for Trypanosoma brucei pteridine reductase 1 inhibition.
    Jedwabny W; Panecka-Hofman J; Dyguda-Kazimierowicz E; Wade RC; Sokalski WA
    J Comput Aided Mol Des; 2017 Aug; 31(8):715-728. PubMed ID: 28688090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Innovative Folate Inhibitors Leveraging the Amino Dihydrotriazine Motif from Cycloguanil for Their Potential as Anti-
    Francesconi V; Rizzo M; Pozzi C; Tagliazucchi L; Konchie Simo CU; Saporito G; Landi G; Mangani S; Carbone A; Schenone S; Santarém N; Tavares J; Cordeiro-da-Silva A; Costi MP; Tonelli M
    ACS Infect Dis; 2024 Jul; ():. PubMed ID: 38953453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.